425: Strive, Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive's CEO Matthew Cole posting about the transaction on X.com.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The announcement was made via a communication posted on X.com by Matthew Cole, CEO of Strive, Inc., on September 24, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a cautionary statement and informational notice about a proposed merger. It balances potential benefits with numerous risks, making it neither overtly positive nor negative.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the business combination.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close when expected or at all if conditions to closing are not met or satisfied timely.
• Potential legal proceedings could be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets could impact the combined company.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could affect the transaction's outcome.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.

Future Outlook

The future outlook centers on the successful completion and integration of the proposed business combination between Strive and Semler Scientific, with expectations of strategic and financial benefits. However, this outlook is subject to significant risks, including those related to market conditions, regulatory changes, integration challenges, and the volatility of Bitcoin and other digital assets, which are part of the combined company's potential treasury strategies.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted a communication on X.com on September 24, 2025, in connection with the proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of 'Bitcoin treasury strategies' and 'risks associated with Bitcoin and other digital assets' indicates a growing trend among companies to explore or adopt digital assets as part of their corporate financial management, reflecting a broader industry shift towards integrating cryptocurrency into traditional finance, albeit with acknowledged volatility and regulatory risks.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions to the announcement or completion of the proposed transaction.
• Business and employee relationships at both companies could change as a result of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The proposed business combination between Strive and Semler Scientific presents potential strategic and financial benefits, but also carries substantial risks, including integration challenges, market conditions, and the volatility associated with Bitcoin and digital assets. Investors should hold positions and await further details from the S-4 filing and proxy statement to assess the full implications and valuation of the combined entity before making further investment decisions.

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, Bitcoin treasury strategies, digital assets, corporate governance